IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.66% | -1.43% | -5.52% | -5.00% | -3.82% |
| Total Depreciation and Amortization | 5.86% | 6.16% | 15.96% | 39.09% | 74.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.42% | 15.45% | 35.45% | 32.62% | 33.38% |
| Change in Net Operating Assets | 1,164.29% | -592.16% | 54.02% | 96.45% | 96.70% |
| Cash from Operations | 18.76% | -3.47% | 5.55% | 7.16% | 11.78% |
| Capital Expenditure | 52.07% | 68.83% | 87.38% | 91.29% | 93.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 52.07% | 68.83% | 87.38% | 91.29% | 93.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.47% | 0.50% | 18.87% | 0.39% | -23.82% |
| Issuance of Common Stock | -29.26% | -45.88% | 20.93% | -13.68% | 163.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -30.00% | -47.55% | 21.65% | -14.58% | 172.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -151.62% | -427.06% | 40.18% | 22.61% | 110.16% |